Parents’ history of hypertension, diabetes, and dyslipidemia with offspring cardiac damage – a 24-year longitudinal study

• by Douglas R Corsi, Andrew O Agbaje

• November 21, 2025

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

• by Xi He, Guanlian He, Liqin Qi, Yujie Chen, Zhaorong Lin, Wenjia Chen, Qintao Huang, Libin Liu, Zhaoyang Chen, Ruonan Gao

• May 15, 2026

An epidemiological assessment of the distribution and sociodemographic burden of chronic diseases: a focus on hypertension, diabetes, and cardiovascular conditions

• by Chidimma Evangeline Oliobi, Dawit Getnet Ayele, Knowledge Chinhamu, Temesgen Zewotir, Retius Chifurira

• May 22, 2026